Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary ACTH Hypersecretion × Deamino Arginine Vasopressin × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1 Pituitary ACTH Hypersecretion 1

Interventions

relacorilant 3 Mifepristone 3 Corlux 3 Cabergoline 3 pasireotide 2 fimepinostat 1 corticorelin ovine 1 Tissue Banks 1 Magnetic Resonance Spectroscopy 1 Deamino Arginine Vasopressin 1 Biomarkers 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04569591 2026-03-18

DDAVP for Pituitary Adenoma

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡